Product Overview
PT-141, or Bremelanotide, represents a breakthrough in the treatment of sexual dysfunction, offering new hope for individuals seeking to enhance sexual desire and performance. Unlike other treatments that focus on the vascular system, PT-141 works by targeting the nervous system to increase sexual desire through the activation of the melanocortin receptors. This innovative approach provides an effective solution for erectile dysfunction in men and hypoactive sexual desire disorder in women, fostering deeper connections and more fulfilling sexual experiences.
PT-141, also known as Bremelanotide, is a peptide used primarily to treat sexual dysfunction in both men and women. It works by stimulating the nervous system to increase sexual desire and arousal, rather than targeting the vascular system like traditional ED medications.
PT-141 is typically administered via subcutaneous injection, usually into the fatty tissue of the abdomen or thigh. It should be injected about 45 minutes to an hour before sexual activity, or as directed by a healthcare provider.
As with any medication, PT-141 can have side effects, though they are generally mild and temporary. Common side effects may include nausea, flushing, headache, or injection site reactions. More serious side effects are rare but can occur. If you experience any severe side effects or have concerns about the medication, it's important to consult with your healthcare provider.